Behcet’s-like disease in a patient treated with Ixekizumab for chronic plaque psoriasis

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Wolfgang Hueber, Bruce E. Sands, Steve Lewitzky et al. · Gut · 2012 · 1.5K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials

Andrew D. Dick, İlknur Tuğal-Tutkun, Stephen C. Foster et al. · Ophthalmology · 2013 · 365 citations

Medicine, Immunology, Ophthalmology +9

The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24

Wai Po Chong, Mary J. Mattapallil, Kumarkrishna Raychaudhuri et al. · Immunity · 2020 · 176 citations · Full text

Life Sciences, Immunology, Pathology +16

Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study

Gerardo Di Scala, Alessandra Bettiol, Rafaela Diana Cojan et al. · Journal of Autoimmunity · 2018 · 78 citations

Life Sciences, Immunology, Internal Medicine +15

Secukinumab induced Behçet’s syndrome: a report of two cases

Elif Dincses, Berna Yurttaş, Sinem Nihal Esatoğlu et al. · Oxford Medical Case Reports · 2019 · 45 citations · Full text

Life Sciences, Immunology, Autoimmunity +16